Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Zicam Cough** is a homeopathic over-the-counter cough spray marketed under the Zicam brand, primarily containing zinc (as zinc gluconate or similar zinc compounds) as the key active ingredient. It is designed to soothe irritated throat and bronchial passages, thereby reducing the cough reflex associated with common cold symptoms. Unlike conventional pharmaceuticals, it leverages homeopathic dilutions of zinc (e.g., Zincum gluconicum) to purportedly shorten cold duration and relieve symptoms like cough and sore throat when used at the first sign; however, it is not formulated for flu or allergies. The product is manufactured in various flavors such as cherry and administered via oral spray, with warnings for persistent symptoms requiring medical consultation.[1][2][13]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zicam Cough.